BIOLOGICAL · Unmapped registry intervention
beta-glucan MM-10-001
Find medicine records ·
Find other trials using this name
Clinical trial
Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT00857025
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
flow cytometry
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
questionnaire administration
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBeta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
beta-glucan MM-10-001BIOLOGICAL
flow cytometryOTHER
Sponsors & collaborators
City of Hope Medical Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00857025 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.